🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

At Generation Bio, we commit to bring out the best in our team so they can bring out the best in us. Want to join us in doing great things in #geneticmedicine? Explore our current opportunities #biotechjobs: bit.ly/3FikjCg

Our mission to help people live fuller lives starts with our team. If we thrive both as a community and individually, we are empowered to do the best work we can do. Learn more about joining the team: bit.ly/2ZvDMvt #biotechjobs

Are you an out of the box thinker? Our DMPK team is growing and we’re looking for a #Scientist to join us in innovating genetic medicines for people living with rare and prevalent diseases. Sound interesting? View the role: bit.ly/3N1YQ31 #biotechjobs

On #PKUday we support those living with #PKU and their families in raising awareness about the need for better treatment options. At Generation Bio, we aim to develop #geneticmedicines for people living with PKU and other genetic diseases caused by inborn errors of metabolism.

At Generation Bio, we have a core value of being all-in for our mission. To maintain that dedication, sometimes we have to hit pause. Every year, we take the week of July 4th off to reflect and recharge. Read more about our annual shutdown: bit.ly/3yuMj3N

We are thrilled to welcome Dannielle Appelhans to our Board of Directors! As COO of 0lameiamoAlba || and previously Novartis, Dannielle brings extensive leadership experience in strategy and operations. Read more about her appointment here: bit.ly/3o9txZt

Tomorrow morning, we will participate in a fireside chat at the 2022 Jefferies Cell and Genetic Medicine Summit. You can access the live webcast on the Events page of our website: buff.ly/3BZ3GKC

To recognize #NHHM, we celebrated the best way we know how: with food, festivities and learning. A big thank you to members of the GBio community who shared their cultures and backgrounds with us - especially Mariachi Guadalajara en Boston (pictured below)!

As 2022 comes to a close, we are proud to recognize each of our dedicated employees who have helped us continue our work towards unlocking the full potential of #geneticmedicine and look forward to working together towards our vison of a world without genetic disease in 2023.

Today, our President & CEO, Geoff McDonough, will present at the 41st Annual J.P. Morgan HealthCare Conference. Details here: buff.ly/3ZqLiF3 #JPM2023

Today, our CEO, Geoff McDonough, will participate in the Gene Therapy panel discussion at the 43rd Annual TD Cowen Healthcare Conference in Boston. Learn more here: buff.ly/41Mvs99

We are pleased to share that we’re teaming up with Moderna on a journey to unlock the full potential of genetic medicine through the development of non-viral DNA therapeutics. Learn more: buff.ly/40plR7f

Today, our CEO, Geoff McDonough, will participate in a fireside chat at the 42nd Annual Needham Virtual Healthcare Conference. Learn more here: buff.ly/43IEN2x

Today, our CFO, Matt Norkunas, M.D., will present at the JMP Securities Life Sciences Conference in New York. Learn more here: buff.ly/3M9LP8P

Today, our CEO, Geoffrey McDonough, will present at the 2023 Jefferies Healthcare Conference in New York. Learn more: buff.ly/42AtjwA #JefferiesHealthcare

Today, Generation Bio announced an exciting step forward in our mission to realize the full potential of non-viral DNA therapeutics with the development of a proprietary, novel DNA called immune-quiet DNA (iqDNA). Read our press release here to learn more: buff.ly/46Tl4xV

Today, Generation Bio's CEO Geoff McDonough, M.D., presented at the TD Cowen Health Care Conference on our innovative ctLNP-siRNA technology for T cell-driven autoimmune diseases. Catch the replay: bit.ly/gbioevents #GenerationBio #Biotech #TDCowenConference

We recently presented at Cold Spring Harbor Labs on our ctLNP technology for selective delivery of siRNA to T cells. We believe this breakthrough could offers new hope for treating T cell-driven autoimmune diseases. #LNP #siRNA #AutoimmuneDisease #Innovation

Last week, our CEO, Geoff McDonough, participated in a fireside chat at the Needham Healthcare Conference. Geoff highlighted our innovative approach to siRNA therapeutics for T cell-driven autoimmune diseases. To view the replay, visit bit.ly/gbioevents.